Characterising anti-osteoporosis drug users in real world primary care settings in Spain: A data-driven cluster analysis

Characterising anti-osteoporosis drug users in real world primary care settings in Spain: A data-driven cluster analysis

We attempted to characterize the population of anti-osteoporosis drug users by determining groups of patients with similar features.

Dettagli Bibliografici
Autori principali:	Khalid, S, Ali, M, Silman, A, Prieto-Alhambra, D
Natura:	Conference item
Pubblicazione:	Springer 2017

Documenti analoghi

Sub-groups of anti-osteoporosis drug users, and associated fracture risk in real world primary care settings: a data-driven cluster analysis
di: Khalid, S, et al.
Pubblicazione: (2017)

Data-driven cluster analysis for identifying groups within users of anti-osteoporosis medication, using real-world primary care data.
di: Khalid, S, et al.
Pubblicazione: (2017)

Deep learning to detect features of a population of anti-osteoporosis drug users
di: Khalid, S, et al.
Pubblicazione: (2018)

Comparative anti-fracture effectiveness of different anti-osteoporosis medications amongst male drug users in real world clinical practice: a population-based cohort study
di: Zwart, M, et al.
Pubblicazione: (2016)

Deep learning for drug utilisation research: Identifying features within a population of anti-osteoporosis drug users
di: Khalid, S, et al.
Pubblicazione: (2018)

Comparative risk of venous thromboembolism among users of different anti-osteoporosis drugs in the UK National Health Service and in Catalonia, Spain: A propensity-matched cohort study
di: Khalid, S, et al.
Pubblicazione: (2017)

Techniques for characterising long COVID in real world data
di: Kostka, K, et al.
Pubblicazione: (2022)

Comparative risk of acute myocardial infarction among users of different anti-osteoporosis drugs in Catalonia, Spain: A propensity matched cohort study using data from the SIDIAP database
di: Khalid, S, et al.
Pubblicazione: (2017)

Comparative fracture risk amongst users of different anti-osteoporosis therapies: meta-analysis of propensity-matched cohort studies using data from the Clinical Practice Research Datalink (UK) and SIDIAP (Spain).
di: Khalid, S, et al.
Pubblicazione: (2017)

Risk of venous thromboembolism among users of different anti-osteoporosis drugs: a population-based cohort analysis including over 200,000 participants from Spain and the UK
di: Martín-Merino, E, et al.
Pubblicazione: (2017)

Long-term (up to 5 years) persistence with different anti-osteoporosis medications in Catalonia (Spain): a population-based cohort study
di: Carbonell, C, et al.
Pubblicazione: (2013)

Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on “real-world” data: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database
di: Khalid, S, et al.
Pubblicazione: (2018)

Cessation rate of anti-osteoporosis treatments and risk factors in Spanish primary care settings: a population-based cohort analysis
di: Martín-Merino, E, et al.
Pubblicazione: (2017)

Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on “real-world” data: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database
di: Khalid S, et al.
Pubblicazione: (2018-10-01)

Imminent fracture risk amongst new users of oral bisphosphonates in actual practice settings: A multi-national European cohort study from Denmark, Spain, and the UK
di: Khalid, S, et al.
Pubblicazione: (2019)

Risk of venous thromboembolism amongst users of different anti-osteoporosis drugs: a multinational population-based cohort study
di: Martin-Merino, E, et al.
Pubblicazione: (2016)

Comparative risk of venous thromboembolism amongst users of different anti-osteoporosis drugs in the uk: a propensity-matched cohort study using data from the clinical practice research datalink
di: Khalid, S, et al.
Pubblicazione: (2016)

Comparative fracture risk amongst users of different anti-osteoporosis drugs available in the UK in the NHS: A propensity-matched cohort study using data from the Clinical Practice Research Datalink
di: Khalid, S, et al.
Pubblicazione: (2016)

Curator – a data curation tool for clinical real-world evidence
di: Delmestri, A, et al.
Pubblicazione: (2023)

Curator – A data curation tool for clinical real-world evidence
di: Antonella Delmestri, et al.
Pubblicazione: (2023-01-01)

Secular trends of use of anti-osteoporosis treatments in Spain: a population-based cohort study including over 1.5 million people and more than 12 years of follow-up
di: Martín-Merino, E, et al.
Pubblicazione: (2017)

[Degenerative osteoarthritis, osteoporosis and fractures: controversies and evidences].
di: Pagès-Castellà, A, et al.
Pubblicazione: (2013)

Predictors for self-discontinuation of anti-osteoporosis medication: A hospital-based real-world study.
di: Ya-Lian Deng, et al.
Pubblicazione: (2022-01-01)

Predictors for self-discontinuation of anti-osteoporosis medication: A hospital-based real-world study
di: Ya-Lian Deng, et al.
Pubblicazione: (2022-01-01)

Machine learning for feature selection and cluster analysis in drug utilisation research
di: Khalid, S, et al.
Pubblicazione: (2019)

The impact of rheumatoid arthritis on the risk of adverse events following joint replacement: a real-world cohort study
di: Burn, E, et al.
Pubblicazione: (2018)

The impact of rheumatoid arthritis on the risk of adverse events following joint replacement: a real-world cohort study
di: Burn E, et al.
Pubblicazione: (2018-06-01)

1 and 2-year persistence with different anti-osteoporosis medications per previous use and setting of therapy initiation: A population-based cohort study
di: Reyes, C, et al.
Pubblicazione: (2017)

Persistence to anti-osteoporosis treatments in primary care patients recorded in the Spanish electronic database BIFAP
di: Merino, E, et al.
Pubblicazione: (2016)

Treatment patterns for osteoporosis medications in five European countries: a multinational real world cohort analysis
di: Robinson, DE, et al.
Pubblicazione: (2022)

Machine learning for risk factor identification and cardiovascular mortality prediction among patients with osteoporosis
di: Hasheminasab, AH, et al.
Pubblicazione: (2023)

Artrosis, osteoporosis y fracturas: controversias y evidencias
di: Pagès-Castellà, A, et al.
Pubblicazione: (2013)

Characterisation of a Real-World Søderberg Electrode
di: Ralph Ivor Glastonbury, et al.
Pubblicazione: (2020-12-01)

The association between keloid and osteoporosis: real-world evidence
di: Chun-Ching Lu, et al.
Pubblicazione: (2021-01-01)

2-year persistence with different anti-osteoporosis medications: a population-based cohort
di: Reyes, C, et al.
Pubblicazione: (2017)

Clustering Users Based on Hearing Aid Use: An Exploratory Analysis of Real-World Data
di: Alessandro Pasta, et al.
Pubblicazione: (2021-09-01)

THE EUROPEAN-PROSPECTIVE-OSTEOPOROSIS-STUDY (EPOS)
di: Reeve, J, et al.
Pubblicazione: (1993)

Assessment of cardiovascular safety of anti-osteoporosis drugs
di: Fuggle, NR, et al.
Pubblicazione: (2020)

Two-fold regional variation in initiation of anti-osteoporosis medication after hip fracture in the UK
di: Shah, A, et al.
Pubblicazione: (2016)

Two-fold regional variation in initiation of anti-osteoporosis medication after hip fracture in the UK
di: Shah, A, et al.
Pubblicazione: (2016)